Holotomography meets microfluidics: Advancing patient-derived organoid drug screening

Online Webinar - Presentation

-

Thursday 11 December 2025 - 15:00

Holotomography meets microfluidics: Advancing patient-derived organoid drug screening
Post publication date: 
Monday, December 1, 2025

Tomocube and Okomera joint webinar to unveil integrated workflow for functional precision medicine

We are excited to announce an upcoming joint webinar with Okomera, a pioneer in droplet-based microfluidic organoid screening, titled “Holotomography Meets Microfluidics: Patient-derived organoid drug screening.” Scheduled for December 11, 2025, this session will showcase how the combination of label-free 3D holotomography and high-throughput microfluidics can transform preclinical drug testing and functional precision oncology.

Related products 

Holotomographic Microscope for 3D Label-Free Imaging of Samples
A compact design with flexible configuration, delivering uncompromised quality and making advanced Holotomography imaging accessible for every lab.
High-Performance Holotomography microscope for imaging at scale

Partner 

Tomocube, Inc